Ledger.Open graph →
SEC Form D · filed November 14, 2022

Serina Therapeutics, Inc

Offering
$3.6M
Sold
$3.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HUNTSVILLE, AL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Michael D. Bentley · Huntsville, ALExec · DirectorRandall W. Moreadith · Huntsville, ALExec · DirectorBarbara M. Fisk · Madison, ALDirectorJames R. Hudson, Jr · Huntsville, ALDirectorTacey R. Viegas · Madison, ALExecMiguel A. Loya · Houston, TXDirectorPatrick J. Haynes, Iii · Chicago, ILDirectorAlan Rutledge · San Francisco, CAExec · DirectorJ M. Harris · Huntsville, ALExec · DirectorNancy C. Floyd · Washington, Washington, D.C.DirectorVincent L. Ammann · Washington, Washington, D.C.Exec · DirectorRoberta W. Sims · Washington, Washington, D.C.DirectorGeorge P. Clancy · Washington, Washington, D.C.ExecJeffrey Fried · Elmhurst, NYDirectorJason Carss · New York, NYExec · DirectorJ M. Harris · Huntsville, ALExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗